Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial

Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia, Renan Nascimento Barros, Dirce Costa Onety, Karla Cristina Petruccelli Israel, Emilyn Oliveira Guerreiro, José Erique Miranda Medeiros, Raquel Neves Nicolau, Luiza Fernanda Mendonça Nicolau, Rafael Xavier Cunha, Maria Fernanda Rodrigues Barroco, Patrícia Souza da Silva, Raysa Wanzeller de Souza Paulain, Claudia Elizabeth Thompson, Andy Goren, Carlos Gustavo Wambier, Flávio Adsuara Cadegiani
doi: https://doi.org/10.1101/2021.06.28.21259661

Data Availability

Data is available in case request is approved by the research team.

Back to top
Posted July 13, 2021.
Download PDF
Data/Code
Email
Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia, Renan Nascimento Barros, Dirce Costa Onety, Karla Cristina Petruccelli Israel, Emilyn Oliveira Guerreiro, José Erique Miranda Medeiros, Raquel Neves Nicolau, Luiza Fernanda Mendonça Nicolau, Rafael Xavier Cunha, Maria Fernanda Rodrigues Barroco, Patrícia Souza da Silva, Raysa Wanzeller de Souza Paulain, Claudia Elizabeth Thompson, Andy Goren, Carlos Gustavo Wambier, Flávio Adsuara Cadegiani
medRxiv 2021.06.28.21259661; doi: https://doi.org/10.1101/2021.06.28.21259661
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area